Significance and limitations of the use of next-generation sequencing technologies for detecting mutational signatures
- 1 November 2021
- journal article
- research article
- Published by Elsevier in DNA Repair
- Vol. 107, 103200
Abstract
No abstract availableKeywords
Funding Information
- Cancer Research UK (C98/A24032)
- National Institutes of Health
- NIEHS (R01ES030993-01A1, R01ES032547)
This publication has 98 references indexed in Scilit:
- The Cancer Genome Atlas Pan-Cancer analysis projectNature Genetics, 2013
- Signatures of mutational processes in human cancerNature, 2013
- EMu: probabilistic inference of mutational processes and their localization in the cancer genomeGenome Biology, 2013
- Deciphering Signatures of Mutational Processes Operative in Human CancerCell Reports, 2013
- Mutational Processes Molding the Genomes of 21 Breast CancersCell, 2012
- International network of cancer genome projectsNature, 2010
- Mutation patterns in cancer genomesProceedings of the National Academy of Sciences, 2009
- The cancer genomeNature, 2009
- Next-generation DNA sequencingNature Biotechnology, 2008
- Initial sequencing and analysis of the human genomeNature, 2001